RANKL-independent osteoclastogenesis in Paget's disease

RANKL-independent osteoclastogenesis in Paget's disease

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jones, F, Knowles, H, Wass, J, Athanasou, N
Formáid:	Journal article
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
de réir: Neale, S, et al.
Foilsithe / Cruthaithe: (2000)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
de réir: Taylor, R, et al.
Foilsithe / Cruthaithe: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
de réir: Taylor, R, et al.
Foilsithe / Cruthaithe: (2011)

Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
de réir: Neale, S, et al.
Foilsithe / Cruthaithe: (2000)

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
de réir: Sun, S, et al.
Foilsithe / Cruthaithe: (2006)

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
de réir: Mizuho Kittaka, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
de réir: Guoyou Zhang, et al.
Foilsithe / Cruthaithe: (2019-10-01)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
de réir: Hemingway, F, et al.
Foilsithe / Cruthaithe: (2011)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
de réir: Hemingway, F, et al.
Foilsithe / Cruthaithe: (2011)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
de réir: Mohammed S. AlQranei, et al.
Foilsithe / Cruthaithe: (2021-03-01)

RANKL-Expressing Ectopic Extramammary Paget’s Disease on the Lower Abdomen
de réir: Akiko Hagiwara-Takita, et al.
Foilsithe / Cruthaithe: (2016-06-01)

RANKL signaling and osteoclastogenesis is negatively regulated by cardamonin.
de réir: Bokyung Sung, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT
de réir: Hemingway, F, et al.
Foilsithe / Cruthaithe: (2013)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT.
de réir: Hemingway, F, et al.
Foilsithe / Cruthaithe: (2013)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
de réir: Lau, Y, et al.
Foilsithe / Cruthaithe: (2007)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
de réir: Jiarui Li, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Inhibitory activity on RANKL-mediated osteoclastogenesis of Glossogyne tenuifolia extract
de réir: Shih-Wei Wang, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
de réir: Weiduo Hou, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
de réir: Yurui Jiao, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner.
de réir: Akiko Kukita, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
de réir: Sabokbar, A, et al.
Foilsithe / Cruthaithe: (2001)

Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
de réir: Zhang, T, et al.
Foilsithe / Cruthaithe: (2018)

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
de réir: Costanzo Padovano, et al.
Foilsithe / Cruthaithe: (2023-12-01)

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors
de réir: Věra Hedvičáková, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
de réir: Ye Xiaoshuang, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
de réir: Dahu Qi, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Inhibitory Effect of Chlorpromazine on RANKL-Induced Osteoclastogenesis in Mouse Bone Marrow Cells
de réir: Hiroharu Kawamura, et al.
Foilsithe / Cruthaithe: (2011-01-01)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
de réir: Chenhui Cai, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
de réir: Zeyuan Zhong, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Direct identification of osteoblast progenitor cells in Paget's disease
de réir: Joyner, C, et al.
Foilsithe / Cruthaithe: (1999)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
de réir: Itonaga, I, et al.
Foilsithe / Cruthaithe: (2002)

Giant-cell-rich pseudotumour in Paget's disease.
de réir: Gamage, N, et al.
Foilsithe / Cruthaithe: (2013)

Chemotherapy-induced adipocyte senescence triggers bone loss through RANKL-mediated osteoclastogenesis
de réir: Ganesh Kumar Raut, et al.
Foilsithe / Cruthaithe: (2024-04-01)

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo
de réir: Yufeng Deng, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
de réir: Chenguang Niu, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
de réir: Feng-Jen Tseng, et al.
Foilsithe / Cruthaithe: (2015-07-01)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
de réir: Joo-Hee Choi, et al.
Foilsithe / Cruthaithe: (2018-08-01)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
de réir: Yunfei Zhan, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Oligomeric proanthocyanidins ameliorates osteoclastogenesis through reducing OPG/RANKL ratio in chicken's embryos
de réir: Gengsheng Yu, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
de réir: Kazuaki Miyagawa, et al.
Foilsithe / Cruthaithe: (2023-07-01)